Ran Luo
Impact in
- Infectious Diseases top 1%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- Nephrology top 1%
- Acute Kidney Injury Research
Papers in
-
- Natural product bioactivities and synthesis 3
-
- Acute Kidney Injury Research 4
- Renal Diseases and Glomerulopathies 4
- Co-authors
- Shuwang Ge (22 shared papers)Gang Xu (20 shared papers)Yichun Cheng (19 shared papers)Ying Yao (4 shared papers)Lei Dong (3 shared papers)Junhua Li (4 shared papers)Meng Zhang (1 shared paper)Zhixiang Wang (1 shared paper)
In The Last Decade
Ran Luo
48 papers receiving 2.6k citations
Ran Luo's Hit Papers
Peers
Comparison fields: 5 of 119
- Infectious Diseases 1.3k
- Nephrology 381
- Neurology 447
- Obstetrics and Gynecology 129
- Oncology 391
Countries citing papers authored by Ran Luo
This map shows the geographic impact of Ran Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Luo more than expected).
Fields of papers citing papers by Ran Luo
This network shows the impact of papers produced by Ran Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Luo. The network helps show where Ran Luo may publish in the future.
Co-authors
The 25 scholars most cited alongside Ran Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 50 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Kidney disease is associated with in-hospital death of patients with COVID-19 Hit paper breakdown → | 2020 | 1840 |
| 2 | 2018 | 81 | |
| 3 | 2020 | 78 | |
| 4 | 2018 | 74 | |
| 5 | 2021 | 61 | |
| 6 | 2018 | 44 | |
| 7 | 2023 | 33 | |
| 8 | 2022 | 32 | |
| 9 | 2020 | 32 | |
| 10 | 2020 | 30 | |
| 11 | 2022 | 27 | |
| 12 | 2021 | 24 | |
| 13 | 2018 | 23 | |
| 14 | 2022 | 22 | |
| 15 | 2019 | 21 | |
| 16 | 2018 | 21 | |
| 17 | 2016 | 17 | |
| 18 | 2016 | 17 | |
| 19 | 2022 | 14 | |
| 20 | 2020 | 13 |
About Ran Luo
Ran Luo is a scholar working on Molecular Biology, Nephrology, Oncology, Immunology and Radiology, Nuclear Medicine and Imaging, having authored 50 papers that have together received 2.7k indexed citations. Recurring topics across this work include MRI in cancer diagnosis (4 papers), Acute Kidney Injury Research (4 papers), Renal Diseases and Glomerulopathies (4 papers), Natural product bioactivities and synthesis (3 papers), Chemokine receptors and signaling (3 papers), Bioactive Compounds and Antitumor Agents (2 papers), COVID-19 Clinical Research Studies (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Infectious Diseases (1.3k citations), Nephrology (381 citations), Neurology (447 citations), Obstetrics and Gynecology (129 citations) and Oncology (391 citations). Ran Luo has collaborated with scholars based in China, Singapore and India. Frequent co-authors include Shuwang Ge, Gang Xu, Yichun Cheng, Ying Yao, Lei Dong, Junhua Li, Meng Zhang, Zhixiang Wang, Kun Wang and Dengbin Wang. Their work appears in journals such as European Radiology, BMC Nephrology, American Journal of Nephrology, Frontiers in Oncology and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.